The kit is intended for the quantitative determination of soluble Fms-like tyrosine kinase-1 (sFlt-1) in maternal serum using the 6000 DELFIA® Xpress random access immunoanalyzer.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
Feature | Specification |
---|---|
Application | Pre-eclampsia |
Disorders | Pre-Eclampsia |
The kit is intended for the quantitative determination of soluble Fms-like tyrosine kinase-1 (sFlt-1) in maternal serum using the 6000 DELFIA® Xpress random access immunoanalyzer.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
The kit is intended for the quantitative determination of soluble Fms-like tyrosine kinase-1 (sFlt-1) in maternal serum using the 6000 DELFIA® Xpress random access immunoanalyzer. The ratio of sFlt-1/PlGF may be used as an aid in diagnosis of pre-eclampsia and for short term prediction of suspected pre-eclampsia together with other biochemical and clinical information.
Application |
Pre-eclampsia
|
---|---|
Brand |
DELFIA® Xpress
|
Detection Modality |
Time-Resolved Fluorescence (TRF)
|
Disorders |
Pre-Eclampsia
|
Instrument Compatibility |
DELFIA Xpress
|
Sample Type |
Serum
|
Technology |
DELFIA
|
Unit Size |
48 assays
|
Are you looking for resources, click on the resource type to explore further.
Brochure for DELFIA prenatal screening solutions and assays including traditional biochemical screening, pre-eclampsia
We are here to answer your questions.